These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks. Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717 [Abstract] [Full Text] [Related]
25. Buflomedil in peripheral arterial disease: trials and tribulations. Conte MS. Circulation; 2008 Feb 12; 117(6):717-9. PubMed ID: 18268159 [No Abstract] [Full Text] [Related]
30. Beta-blockers in the treatment of hypertension: are there clinically relevant differences? Weir MR. Postgrad Med; 2009 May 12; 121(3):90-8. PubMed ID: 19491545 [Abstract] [Full Text] [Related]
31. Predictors of walking distance after supervised exercise therapy in patients with intermittent claudication. Kruidenier LM, Nicolaï SP, Ten Bosch JA, de Bie RA, Prins MH, Teijink JA. Eur J Vasc Endovasc Surg; 2009 Oct 12; 38(4):449-55. PubMed ID: 19540780 [Abstract] [Full Text] [Related]
35. Beta-blockers an important cause of depression: a medical myth without evidence. Kohn R. Med Health R I; 2001 Mar 12; 84(3):92-5. PubMed ID: 11280138 [No Abstract] [Full Text] [Related]